1795.TW
1795.TW
TW0001795003
LOTUS PHARMACEUTICAL CO
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
48.02B EUR
49.68B EUR
53.7B EUR
73.42B EUR
Enterprise Value
100.8B EUR
93.16B EUR
95.49B EUR
113.16B EUR
Valuation Multiples
Trailing P/E
12.69x
13.19x
13.94x
22.35x
Forward P/E
7.59x
--
--
--
Price to Sales
1.69x
1.74x
2.2x
4.65x
Price to Book
2x
2.04x
2.23x
3.09x
EV/Revenue
3.54x
3.27x
3.91x
7.17x
EV/EBITDA
10.96x
9.32x
11.26x
19.16x
Price to FCF (P/FCF)
--
151.55x
53.18x
32.35x
EV/FCF
--
284.16x
94.55x
49.86x
FCF Yield
-0.12%
0.66%
1.88%
3.09%
ende